Thank you to our speakers, sponsors, and delegates who joined us in April for the summit! If you are interested in the 2025 event, please get in touch:

Leverage Next Generation Technologies to Define Size, Cargo & Surface Markers to Demonstrate Consistency & Reproducibility for Quality Confidence

Welcome to the Exosome Characterization & Analytical Development Summit

Empower Exosome Analysis: Accuracy, Standardization, Consistency & Reliability for Regulatory Promise

1 preconference focus day to hone in on solutions to improve your pipeline progression

1 preconference focus day to hone in on solutions to improve your pipeline progression

18+ key speakers sharing new solutions and data

Join 60+ of your peers to have your burning questions on characterization and analytical technologies answered

You could have joined this comprehensive summit and united with biopharma and academic experts in characterization techniques and analytical technologies.

In the ever-evolving exosome field, the past year has witnessed remarkable progress, making the growing need for standardization of techniques and technologies increase. Meeting regulatory needs presents a challenge, highlighting the growing importance of developing resilient techniques. These techniques serve as the cornerstone for exosome therapeutics, complementing advancements in drug delivery applications. 

The Exosome Characterization & Analytical Development Summit offered a comprehensive forum, equipping you with the skills needed to establish robust techniques, select the best instruments, ensure quality, and seamlessly navigate regulatory processes. 

Expert speakers from Rion Therapeutics, Harvard Medical School, Astellas, AbbVie, and many others prepared exclusive presentations based on recent case studies and data, informing attendees about what is to come in the exosome field. You could have networked to ask your burning questions, aid your decision-making, and ultimately progress your pipelines. 

Companies On The 2024 Program:

EV Therapeutics: Immunotherapy EVolved.
EXO Biologics
Shift Bio
Vesigen Therapeutics
Harvard Medical School
George Mason University
Aegle Therapeutics
OmniSpirant Therapeutics

World-Class 2024 Speaker Faculty Included:

Testimonials From Previous Attendees Of The Exosome Series

“I appreciate the calibre of attendees and speakers at Hanson Wade conferences, and this was no exception. Very good group and topics.”


“It was really a great opportunity to share common knowledge and experience with other people in our field and Network.”
Principle Research Scientist

Exocel Bio

Our 2024 Partners

Roosterbio logo

Other Events In The Series